Introduction: The aim was to perform a feasibility study of the new artificial sphincter device ARTUS in human cadavers. ARTUS is a new electro-mechanical device, which may prevent urethral damage due to a new working principle which is to perform only sequential pressure on successive parts of the urethra.
Material And Methods: The implantation of the ARTUS device was performed in six cadavers (3 males, 3 females) with different body mass indices. Subsequently the basic operation data (operation time, cuff size, length of wires, complication) were assessed.
Results: The implantation of the ARTUS device is performed easily by the same technique which is commonly used for the AMS 800 implantation. The mean operation time was 20 minutes. The mean cuff size was 4.5 cm in male and 6 cm in female cadavers. The average length of the wires was 12 cm. The necessary subcutaneous pouch had to be bigger than the space used for the tubes of the AMS 800 device. The study is limited by its preclinical setting.
Conclusions: Our results demonstrate that this new artificial urinary sphincter device can be easily implanted. The technical and surgical approaches are similar to those which are applied in the case of the AMS 800 device. Therefore experienced surgeons will be able to adapt their technique easily.
Download full-text PDF |
Source |
---|
AIDS Res Hum Retroviruses
January 2025
Infectious Diseases Division, Paulista School of Medicine, Federal University of São Paulo, São Paulo, Brazil.
HIV RNA plasma viral load (VL) is the standard surrogate marker to monitor response to antiretroviral treatment (ART). We compared the linearity, repeatability, and concordance of six commercially available HIV RNA VL platforms using clinical samples from patients from Brazilian sites where different HIV-1 subtypes co-circulate. A total of 150 plasma samples from each city were collected in Curitiba, Southern Brazil (subtype C), São Paulo (subtype B), and Santos (BF recombinants), Southeast Brazil.
View Article and Find Full Text PDFEur J Clin Microbiol Infect Dis
November 2024
Laboratoire de Bactériologie-Hygiène Hospitalière, Centre National de Référence Francisella tularensis, Centre Hospitalier Universitaire Grenoble Alpes, CS 10217, Grenoble cedex 9, F-38043, France.
Viruses
April 2024
Microbiology Department, Eastern Pathology Alliance, Norfolk and Norwich University Hospital NHS Foundation Trust, NRP Innovation Centre, Norwich Research Park, Colney, Norwich NR4 7GJ, UK.
DNA assays for viral load (VL) monitoring are key tools in the management of immunocompromised patients with cytomegalovirus (CMV) or Epstein-Barr virus (EBV) infection. In this study, the analytical and clinical performances of the NeuMoDx™ CMV and EBV Quant Assays were compared with artus CMV and EBV QS-RGQ Kits in a primary hospital testing laboratory. Patient plasma samples previously tested using artus kits were randomly selected for testing by NeuMoDx assays.
View Article and Find Full Text PDFDiagn Microbiol Infect Dis
August 2024
Dokuz Eylul University Faculty of Medicine, Department of Medical Microbiology, Division of Medical Virology, Izmir, Turkey.
We aimed to compare the NeuMoDx HBV Assay with the artus HBV Assay using residual plasma samples and to evaluate the discordant results. The study included 200 patient samples analyzed with the NMD assay and stored at -80 °C. Samples were analyzed by artus in 2023.
View Article and Find Full Text PDFFront Med (Lausanne)
February 2023
Department of Ophthalmology, Rothschild Foundation Hospital, Paris, France.
Purpose: The study aimed to assess the safety and the non-inferiority of cataract surgery outside an operating room using the Surgicube, a mobile laminar airflow (LAF) device.
Settings: This single-center study was conducted at the Rothschild Foundation, Paris, France.
Design: This is a retrospective cross-sectional study.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!